Jim Cramer Weighs In on BWX Technologies After 27% Pullback
BWX Technologies (NYSE:BWXT) has seen a 27% drop over three months, partly due to weaker-than-expected quarterly results. Jim Cramer discussed the stock's volatility, noting a recent analyst meeting with bullish long-term targets for 2030. The company plans to sell a majority stake in its medical isotope unit for up to $800 million, reallocating funds to nuclear manufacturing. BWXT projects 2030 revenues of $5.5B-$6B with EBITDA margins expanding to 20%.
How this was made
The 30-second read
Why it matters
The piece is a recap; no fresh catalyst, so limited trading impact.
Market read
Commentary on an already‑priced earnings beat; minimal new trading signal.
What to watch
Potential supply‑chain constraints for SMR production and insider selling could limit upside.
Background
Cramer highlighted BWXT's recent 27% decline, its Q2 results released Aug 3, and upcoming 2030 roadmap.
Ticker impact
Jim Cramer discussed BWXT's 27% pullback and recapped its recent quarter results and guidance.
modest upside as the stock corrects from the pullback
The article provides no new data; it only reiterates existing earnings and guidance, so any price move would be speculative.
Market effects
Limited; reinforces perception of defense‑nuclear sector stability.
U.S. defense and industrial investors may note the commentary.
Low; no broader macro or geopolitical shift.
Counterpoint
The pullback may be over‑reacted; the long‑term moat remains strong.
Key entities
- CompanyBWX Technologies, Inc.
Defense and commercial nuclear equipment maker.
- PersonJim Cramer
Host of Mad Money, providing commentary.
